Target intelligence / Profile preview

T cell receptor beta joining 1-5 (TRBJ1-5)

Target
TRBJ1-5
Molecular classification
Other (gene segment), Immunoglobulin superfamily (as part of complete TCR complex)
01

Overview

TRBJ1-5 (T cell receptor beta joining 1-5) is a joining gene segment in the T cell receptor beta (TCRβ) locus, participating in the V(D)J recombination that produces diverse antigen receptors in T cells. The TCRβ chain is generated by recombination of a variable (TRBV), diversity (TRBD), and joining (TRBJ) segment, with TRBJ1-5 as one of the available joining segments. This process underlies the adaptive immune system's ability to recognize a vast array of antigens. TRBJ1-5 itself is not a standalone protein or drug target, but is critical to immune repertoire formation and can serve as a marker in studies of T cell diversity and clonality.

Other names
TRBJ1-5TRBJ15TCRBJ1S5
02

Biological functions

Generation of immune diversityAntigen recognition (as part of T cell receptor complex—only in context of the rearranged gene in mature T cells)
03

Disease associations

Cancer (by involvement in T cell responses and immunotherapies—indirect)Infection (contributes to antiviral responses—indirectly)Other (marker in T cell receptor repertoire analysis—indirect role)
04

Biomarkers

Used in TCR repertoire sequencing for immune monitoring (i.e., clonality analysis in cancer or infection)

Beyond the preview

Go deeper on T cell receptor beta joining 1-5 (TRBJ1-5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta joining 1-5 (TRBJ1-5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call